MedXCell Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $2.33M

  • Investors
  • 1

MedXCell General Information

Description

Operator of a healthcare group intended to harness the power of cellular therapies to make lives better. The company is engaged in developing and manufacturing innovative cellular therapies and focuses on technologies, techniques, and novel applications in major diseases such as cancer, autoimmune, neurological, and degenerative disorders, enabling medical practitioners to provide patients with safe treatment for a wide range of their needs.

Contact Information

Website
www.medxcell.ch
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Avenue des Planches 20C
  • 1820 Montreux
  • Switzerland
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • Avenue des Planches 20C
  • 1820 Montreux
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MedXCell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 19-Dec-2023 $2.33M Completed Pre-Clinical Trials
2. Later Stage VC (Series A) 04-Jun-2021 Completed Pre-Clinical Trials
1. Seed Round 01-Jan-2018 $1.52M $1.52M Completed Pre-Clinical Trials
To view MedXCell’s complete valuation and funding history, request access »

MedXCell Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 2,880,000 $0.010000 $0.28 $0.28 1x $0.28 2.68%
To view MedXCell’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

MedXCell Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a healthcare group intended to harness the power of cellular therapies to make lives better. The company is
Biotechnology
Montreux, Switzerland
13 As of 2023

South San Francisco, CA
 

Florham Park, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MedXCell Competitors (3)

One of MedXCell’s 3 competitors is Nkarta Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nkarta Therapeutics Formerly VC-backed South San Francisco, CA
Celularity Formerly VC-backed Florham Park, NJ
Fate Therapeutics Formerly VC-backed San Diego, CA
You’re viewing 3 of 3 competitors. Get the full list »

MedXCell Patents

MedXCell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023273967-A1 Trehalose-based surfactants Pending 17-May-2022
EP-4526313-A1 Trehalose-based surfactants Pending 17-May-2022
US-20250304610-A1 Trehalose-based surfactants Pending 17-May-2022
WO-2023222659-A1 Trehalose-based surfactants Inactive 17-May-2022 C07H13/06

MedXCell Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MedXCell Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Genii Capital PE/Buyout Minority
To view MedXCell’s complete investors history, request access »

MedXCell FAQs

  • When was MedXCell founded?

    MedXCell was founded in 2016.

  • Where is MedXCell headquartered?

    MedXCell is headquartered in Montreux, Switzerland.

  • What is the size of MedXCell?

    MedXCell has 13 total employees.

  • What industry is MedXCell in?

    MedXCell’s primary industry is Biotechnology.

  • Is MedXCell a private or public company?

    MedXCell is a Private company.

  • What is the current valuation of MedXCell?

    The current valuation of MedXCell is .

  • What is MedXCell’s current revenue?

    The current revenue for MedXCell is .

  • How much funding has MedXCell raised over time?

    MedXCell has raised $9.7M.

  • Who are MedXCell’s investors?

    Genii Capital has invested in MedXCell.

  • Who are MedXCell’s competitors?

    Nkarta Therapeutics, Celularity, and Fate Therapeutics are competitors of MedXCell.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process